253 related articles for article (PubMed ID: 21693112)
1. Gastric cancer - The role of matrix metalloproteinases in tumor progression.
Lukaszewicz-Zając M; Mroczko B; Szmitkowski M
Clin Chim Acta; 2011 Sep; 412(19-20):1725-30. PubMed ID: 21693112
[TBL] [Abstract][Full Text] [Related]
2. [Molecular biology of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), and the regulation of these genes in tumor tissues].
Takino T; Sato H; Seiki M
Nihon Rinsho; 1995 Jul; 53(7):1791-7. PubMed ID: 7630021
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
4. Biological activity and clinical implications of the matrix metalloproteinases.
Rydlova M; Holubec L; Ludvikova M; Kalfert D; Franekova J; Povysil C; Ludvikova M
Anticancer Res; 2008; 28(2B):1389-97. PubMed ID: 18505085
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases and bladder cancer.
Kanayama H
J Med Invest; 2001 Feb; 48(1-2):31-43. PubMed ID: 11286015
[TBL] [Abstract][Full Text] [Related]
6. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
Groblewska M; Siewko M; Mroczko B; Szmitkowski M
Folia Histochem Cytobiol; 2012 Apr; 50(1):12-9. PubMed ID: 22532131
[TBL] [Abstract][Full Text] [Related]
7. [The significance of metalloproteinases and their inhibitors in gastric cancer].
Lukaszewicz-Zajac M; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw (Online); 2009 Jun; 63():258-65. PubMed ID: 19502687
[TBL] [Abstract][Full Text] [Related]
8. Genetic patterns of metalloproteinases and their tissular inhibitors - clinicopathologic and prognostic significance in colorectal cancer.
Surlin V; Ioana M; Pleşea IE
Rom J Morphol Embryol; 2011; 52(1 Suppl):231-6. PubMed ID: 21424059
[TBL] [Abstract][Full Text] [Related]
9. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Zucker S; Cao J; Chen WT
Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
[TBL] [Abstract][Full Text] [Related]
10. Role of matrix metalloproteinases in melanoma cell invasion.
Hofmann UB; Houben R; Bröcker EB; Becker JC
Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
[TBL] [Abstract][Full Text] [Related]
11. [Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract].
Piura B; Rabinovich A; Huleihel M
Harefuah; 2003 Nov; 142(11):786-91, 804. PubMed ID: 14631913
[TBL] [Abstract][Full Text] [Related]
12. [The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis].
Iwata H; Kobayashi S; Iwase H; Okada Y
Nihon Rinsho; 1995 Jul; 53(7):1805-10. PubMed ID: 7630023
[TBL] [Abstract][Full Text] [Related]
13. [Matrix metalloproteinases and their tissue inhibitors].
Trojanek J
Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study.
Hirano H; Tsuji M; Kizaki T; Sashikata T; Yoshi Y; Okada Y; Mori H
Med Electron Microsc; 2002 Mar; 35(1):16-23. PubMed ID: 12111403
[TBL] [Abstract][Full Text] [Related]
15. Complex roles of tissue inhibitors of metalloproteinases in cancer.
Jiang Y; Goldberg ID; Shi YE
Oncogene; 2002 Mar; 21(14):2245-52. PubMed ID: 11948407
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
Adithi M; Nalini V; Kandalam M; Krishnakumar S
J Pediatr Hematol Oncol; 2007 Jun; 29(6):399-405. PubMed ID: 17551402
[TBL] [Abstract][Full Text] [Related]
17. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.
Gialeli C; Theocharis AD; Karamanos NK
FEBS J; 2011 Jan; 278(1):16-27. PubMed ID: 21087457
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and the thyroid.
Kraiem Z; Korem S
Thyroid; 2000 Dec; 10(12):1061-9. PubMed ID: 11201850
[TBL] [Abstract][Full Text] [Related]
19. [Extracellular matrix degradation enzymes: important factors in liver metastasis of colorectal cancer and good targets for anticancer metastatic therapy].
Ichikawa Y; Ishikawa T; Tanaka K; Togo S; Shimada H
Nihon Geka Gakkai Zasshi; 2001 May; 102(5):376-80. PubMed ID: 11393999
[TBL] [Abstract][Full Text] [Related]
20. [Matrix metalloproteinases and colorectal cancer].
Roeb E; Matern S
Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]